Publication
Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners.
Journal Paper/Review - Jun 27, 2024
Joos Lukas, Gonzalez Chiappe Solange, Neumann Thomas, Mahr Alfred
Units
PubMed
Doi
Contact
Citation
Joos L, Gonzalez Chiappe S, Neumann T, Mahr A. Use of mesna prophylaxis in patients with cyclophosphamide-treated ANCA-associated vasculitis: cross-sectional survey of practitioners. Rheumatol Int 2024; 44:3099-3106.
Type
Journal Paper/Review (English)
Journal
Rheumatol Int 2024; 44
Publication Date
Jun 27, 2024
Issn Electronic
1437-160X
Pages
3099-3106
Brief description/objective
There may be some diversity in the practice of co-prescribing 2-mercaptoethane sodium sulfonate (mesna) with cyclophosphamide (CYC) for ANCA-associated vasculitis (AAV).